Literature DB >> 4683428

Plasma heparin: a unique, practical, submicrogram-sensitive assay.

E T Yin, S Wessler, J V Butler.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4683428

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  24 in total

1.  Anticoagulant activity of heparin in intravenous fluids.

Authors:  T Okuno; C A Nelson
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  CONTROL OF ANTICOAGULANTS DURING OPEN HEART SURGERY.

Authors:  Safuh Attar; René Rivera; David Wilson; Joseph S. McLaughlin
Journal:  Cardiovasc Dis       Date:  1978-03

3.  Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.

Authors:  Peter Hellstern; Juergen Bach; Melanie Simon; Werner Saggau
Journal:  J Extra Corpor Technol       Date:  2007-06

4.  Circadian changes in anticoagulant effect of heparin infused at a constant rate.

Authors:  J F Schved; J C Gris; J J Eledjam
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-27

5.  A low molecular weight heparin in hemodialysis.

Authors:  N Maurin; H Kierdorf
Journal:  Klin Wochenschr       Date:  1988-03-15

6.  Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.

Authors:  A T Culliford; S N Gitel; N Starr; S T Thomas; F G Baumann; S Wessler; F C Spencer
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

7.  The effects of low-dose heparin treatment on patients undergoing transvesical prostatectomy.

Authors:  P O Hedlund; M Blombäck
Journal:  Urol Res       Date:  1981

8.  Heparin stability: effects of diluent, heparin activity, container, and pH.

Authors:  K T Goodall; C C Chooi; A S Gallus
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

Review 9.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 10.  Heparin therapy. Regimens and treatment considerations.

Authors:  T M Hyers
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.